Terms: = Germ cell tumor AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Clinical Outcome
8 results:
1. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
2. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.
Yamazaki Y; Gao X; Pecori A; Nakamura Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Satoh F; Sasano H
Front Endocrinol (Lausanne); 2020; 11():587769. PubMed ID: 33193100
[TBL] [Abstract] [Full Text] [Related]
3. Positive Impact of Genetic Test on the Management and outcome of Patients With Paraganglioma and/or Pheochromocytoma.
Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
[TBL] [Abstract] [Full Text] [Related]
4. Immediate clinical Success After Percutaneous Ablation of Extra-adrenal Paraganglioma.
Ierardi AM; Biondetti P; Ferrante G; Carugo S; Carrafiello G
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1803-1806. PubMed ID: 29922859
[TBL] [Abstract] [Full Text] [Related]
5. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase.
Gupta S; Zhang J; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484
[TBL] [Abstract] [Full Text] [Related]
6. Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster.
Fliedner SM; Shankavaram U; Marzouca G; Elkahloun A; Jochmanova I; Daerr R; Linehan WM; Timmers H; Tischler AS; Papaspyrou K; Brieger J; de Krijger R; Breza J; Eisenhofer G; Zhuang Z; Lehnert H; Pacak K
Neoplasia; 2016 Sep; 18(9):567-76. PubMed ID: 27659016
[TBL] [Abstract] [Full Text] [Related]
7. Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas.
Oudijk L; van Nederveen F; Badoual C; Tissier F; Tischler AS; Smid M; Gaal J; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger R; Favier J
PLoS One; 2015; 10(3):e0121361. PubMed ID: 25794004
[TBL] [Abstract] [Full Text] [Related]
8. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
Schovanek J; Martucci V; Wesley R; Fojo T; Del Rivero J; Huynh T; Adams K; Kebebew E; Frysak Z; Stratakis CA; Pacak K
BMC Cancer; 2014 Jul; 14():523. PubMed ID: 25048685
[TBL] [Abstract] [Full Text] [Related]